Regeneus extends reach of HiQCell® stem cell therapy to Melbourne – Proactive Investors Australia Proactive Investors AustraliaRegenerative medicine company Regeneus (ASX: RGS) has started offering its HiQCell 2013-10-30 2013-10-30 Michael Zand NEWS Share EmailXFacebookGoogle +PinterestTumblrLinkedinVkontakte About Michael Zand Leave a ReplyYour email address will not be published. Required fields are marked * Save my name, email, and website in this browser for the next time I comment. Δ This site uses Akismet to reduce spam. Learn how your comment data is processed. We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkNoPrivacy policy